Last updated on December 2019

Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)


Brief description of study

Primary Objective:

  • To demonstrate that sotagliflozin reduces cardiovascular (CV) mortality and morbidity (composite of CV death or hospitalization for heart failure [HHF]) compared to placebo in hemodynamically stable patients with type 2 diabetes (T2D) and heart failure (HF) with left ventricular ejection fraction (LVEF) <50%, after admission for worsening heart failure (WHF).
  • To demonstrate that sotagliflozin reduces cardiovascular (CV) mortality and morbidity (composite of CV death or hospitalization for heart failure [HHF]) compared to placebo in hemodynamically stable patients with T2D and HF irrespective of LVEF after admission for WHF.

Secondary Objectives:

  • To demonstrate that, when compared to placebo in the toal patient population, sotagliflozin reduces the total number (i.e., including recurrent events) of the following clinical events:
  • Cardiovascular death, HHF or urgent HF visit.
  • To demonstrate that, when compared to placebo, sotagliflozin reduces:
  • The composite of positively adjudicated sustained 50% decrease in eGFR, chronic dialysis, renal transplant or positively adjudicated sustained eGFR <15 mL/min/1.73 m2 in the total patient population.
  • Cardiovascular death in patients with LVEF < 50%.
  • Cardiovascular death in the total patient population.
  • All-cause mortality in patients with LVEF < 50%.
  • All cause mortality in the total patient population.
  • To demonstrate the safety and tolerability of sotagliflozin in the total population in this study.

Detailed Study Description

The estimated study duration for a given patient will be approximately 3 to 32 months.

Clinical Study Identifier: NCT03521934

Find a site near you

Start Over

Investigational Site Number 8400007

Redondo Beach, CA United States
  Connect »

Investigational Site Number 8400057

Port Charlotte, FL United States
  Connect »

Investigational Site Number 8400067

Arlington Heights, IL United States
  Connect »

Investigational Site Number 8400014

Oklahoma City, OK United States
  Connect »

Investigational Site Number 0320002

Ciudad De Buenos Aires, Argentina
  Connect »

Investigational Site Number 0320028

San Miguel De Tucuman, Argentina
  Connect »

Investigational Site Number 0320019

San Miguel De Tucuman, Argentina
  Connect »

Investigational Site Number 2760011

Rotenburg An Der Fulda, Germany
  Connect »

Investigational Site Number 4100001

Hwaseong-Si, Korea, Republic of
  Connect »

Investigational Site Number 4100005

Seongnam-Si, Korea, Republic of
  Connect »

Investigational Site Number 6430018

Nizhniy Novgorod, Russian Federation
  Connect »

Investigational Site Number 6430013

Rostov-Na-Donu, Russian Federation
  Connect »

Investigational Site Number 6430011

Saint-Petersburg, Russian Federation
  Connect »

Investigational Site Number 6430007

St-Petersburg, Russian Federation
  Connect »

Investigational Site Number 6430012

St-Petersburg, Russian Federation
  Connect »

Investigational Site Number 6430009

St-Petersburg, Russian Federation
  Connect »

Investigational Site Number 7240005

Las Palmas De Gran Canaria, Spain
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 8400072

Elk Grove Village, IL United States
  Connect »

Investigational Site Number 8400044

Natrona Heights, PA United States
  Connect »

Investigational Site Number 8400101

New Braunfels, TX United States
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 8400078

Winston-Salem, NC United States
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 8400128

Alexander City, AL United States
  Connect »

Investigational Site Number 2500013

Vandoeuvre-Les-Nancy Cedex, France
  Connect »

Investigational Site Number 6430025

St-Petersburg, Russian Federation
  Connect »

Investigational Site Number 7030003

Bratislava 3 - Kramare, Slovakia
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »

Investigational Site Number 8400127

National City, CA United States
  Connect »

Investigational Site Number 7240009

San Sebastián De Los Reyes, Spain
  Connect »